Vical to Update Herpes Simplex Vaccine Program at Keystone Conference
(GlobeNewswire via COMTEX) -- Vical Incorporated (VICL 2.26, +0.00, +0.01%) today announced that the company's Vice President of Clinical Development, Richard T. Kenney, M.D., is presenting preclinical results from the company's herpes simplex type 2 (HSV-2) vaccine program in a poster session Friday morning at the Keystone Symposium on Immunological Mechanisms of Vaccination (Seattle, October 27 -- November 1).
posted by blog manager at
6:25 PM
3 Comments:
Medical tourism India process is being facilitated by the corporate sector involved in medical care as well as the tourism industry - both private and public.
I like your Blog.Health is one of the most important components in life.Paula Deen Cookware is available in a wide variety of sizes, designs and makes. You can choose one that suits your taste perfectly
Welldone,I got useful information from your Blog.I will share this on facebook on social networking site .
production support
Post a Comment
Subscribe to Post Comments [Atom]
<< Home